Company Filing History:
Years Active: 2025
Title: Mi-Young Cho: Innovator in Cancer Treatment
Introduction
Mi-Young Cho is a prominent inventor based in South Korea, known for her contributions to the field of cancer treatment. She has developed innovative antibodies that target specific proteins involved in cancer progression. Her work is significant in advancing therapeutic options for patients.
Latest Patents
Mi-Young Cho holds several notable patents, including:
1. **Anti C-Met Antibody And Uses Thereof** - This patent describes an anti c-Met antibody or antibody fragment, along with a pharmaceutical composition that includes the antibody. It outlines a method for preventing and treating cancer by administering the antibody to a subject.
2. **Antibody Specifically Binding To Epitope In Sema Domain Of C-Met** - This patent details an antibody or antigen binding fragment that specifically binds to an epitope in the SEMA domain of the c-Met protein. It also covers related pharmaceutical compositions, methods, kits, nucleic acids, and cells.
Career Highlights
Mi-Young Cho is currently employed at Samsung Electronics Co., Ltd., where she continues to innovate in the field of biotechnology. Her work focuses on developing therapeutic antibodies that can significantly impact cancer treatment.
Collaborations
Mi-Young Cho collaborates with Kwang-Ho Cheong, who is also involved in research and development in the same field. Their partnership enhances the potential for groundbreaking discoveries in cancer therapies.
Conclusion
Mi-Young Cho is a dedicated inventor whose work in developing anti-cancer antibodies is paving the way for new treatment options. Her contributions to the field are invaluable and demonstrate the importance of innovation in healthcare.